Catalogued variously as a functionalized pyrrolidine enantiomer and a protected trans-4-hydroxy-L-proline scaffold, 1-tert-butyl 2-methyl (2R,4S)-4-hydroxypyrrolidine-1,2-dicarboxylate (CAS 114214-55-6, empirical formula C11H19NO5, molecular weight 245.27 g·mol−1) supplies a differentiated three‑point handle for downstream elaboration: the N-Boc carbamate, the C‑2 methyl ester, and the free secondary alcohol fixed in a defined 2R,4S absolute configuration. On‑lot HPLC purity (254 nm, C18 gradient) routinely exceeds 98.5 area‑% and chiral LC (Chiralpak® AS‑RH, 25 °C) returns an enantiomeric excess of ≥ 99.0 %, ensuring that stereochemical leakage—commonly observed when forced epimerization occurs at C‑2 during base‑mediated ester hydrolysis—is absent at the point of release. Specific optical rotation [α]D20 measured in chloroform (c = 1.0) lies in the range −58.0° to −62.5°, consistent with the L‑proline absolute configuration; deviation beyond this band correlates with epimer contamination or residual solvent retained above the 0.5 wt% threshold specified by headspace GC according to Ph. Eur. 2.4.24.
When N-Boc Protection and Methyl Esterification Collide: Stability Gateways Under Basic and Acidic Stress
Dual protection is rarely inert, and the synchronous presence of a base‑labile methyl ester and an acid‑labile Boc group imposes a processing window narrower than that tolerated by either monofunctional building block. Thermogravimetric analysis of a representative batch (TA Instruments Q500, N2 ramp 10 °C·min−1) placed the onset of rapid mass loss at 168 °C, yet decomposition exotherms detected by differential scanning calorimetry (DSC, 5 °C·min−1, crimped Al pan) emerged as low as 98 °C when trace (0.1 mol %) triethylamine hydrochloride was present as a process contaminant. This exotherm, absent in the neat sample, is attributed to premature Boc deblocking that liberates isobutylene and initiates autocatalytic degradation of the pyrrolidine ring. Consequently, operator protocols for large‑scale amide coupling (e.g., HATU‑mediated activation at 0–5 °C in DMF) specify pre‑drying of the solid at 40 °C under 5 mbar for 16 h when ambient relative humidity exceeds 60 %, preventing adventitious water from hydrolyzing the methyl ester during activation. In process analytical technology (PAT)‑instrumented kilo‑lab reactors, in‑situ ReactIR monitoring of the ester carbonyl stretch at 1745 cm−1 provides real‑time verification that saponification has not breached a 2 % threshold before the subsequent benzyl ester transesterification step.
Shelf‑life under sealed, refrigerated (2–8 °C) conditions is classified at 36 months based on ICH Q1A(R2) accelerated stability protocols (40 °C/ 75 % RH for 6 months), with a retest window of 12 months once the container is opened. Incompatibility with strong nucleophiles—particularly lithium aluminium hydride at temperatures above −20 °C—is absolute, as competitive reduction of the methyl ester to the primary alcohol proceeds at a rate 4.2 times that of amide bond formation under the same stoichiometric conditions, measured by stopped‑flow IR kinetics in THF.
A recurring failure observed on production‑scale hydrogenolysis lines (Parr stirred reactors, 5 bar H2, 10 wt% Pd/C, ethanol) is the formation of a des‑Boc impurity via in situ‑generated formic acid when CO2 purging is incomplete. The contaminant, identified as methyl (2R,4S)-4-hydroxypyrrolidine-2-carboxylate, co‑crystallizes with the target compound in methyl tert‑butyl ether / heptane mixtures and depresses melting point by 12 °C at 3 mol % incorporation. Mitigation employs a nitrogen‑sparged solvent pre‑treatment and an on‑line pCO2 sensor maintaining ≤ 50 ppm in the reactor headspace.Stereochemical Integrity and Synthetic Utility of the cis‑4‑Hydroxy Motif
The (2R,4S) arrangement anchors the 4‑hydroxyl group in a 1,3‑syn relationship to the carboxylate‑derived appendage, a regiochemistry central to the pharmacophore of numerous protease inhibitors. In the synthesis of hepatitis C virus NS3/4A serine protease inhibitors (e.g., boceprevir and telaprevir series), the free alcohol serves as the point of attachment for a macrocyclic linker without requiring a separate oxidation‑reduction sequence that would necessitate chromatographic separation of diastereomeric intermediates. Functionalization via Mitsunobu inversion (DIAD, PPh3, 0 °C to 25 °C) inverts the 4‑position to yield the trans‑4‑substituted enantiomer with retention of Boc and methyl ester integrity when benzoic acid is employed as the nucleophile; product assay after aqueous workup records 94 % inverted product with < 1 % epimer at C‑2 (chiral SFC, 210 nm).
An under‑appreciated bottleneck in kilo‑laboratory campaigns is the pronounced tendency of the free hydroxyl group to form intermolecular hydrogen‑bonded oligomers that create transient gel phases during concentration from dichloromethane solutions. Dynamic light scattering (Malvern Zetasizer Nano) of a 100 mM CH2Cl2 solution at −5 °C reveals aggregates with a hydrodynamic radius of 82 nm that collapse above 15 °C; jacket‑controlled thin‑film evaporators operating at 20 °C and 80 mbar eliminate this gel point entirely, allowing transfer to the next step without hold‑up.
How Does It Differ From the Free Acid, the Dimethyl Analogue, and the cis‑4‑Fluoro Derivative?
Four close structural relatives populate the same screening library and are frequently cross‑referenced during route scouting. Table 1 lays out the key differentiating attributes that dictate reactor selection and isolation method.
| Compound | Molecular weight (g·mol−1) | Melting point range (°C) | Solubility in THF at 25 °C (g·L−1) | Key process divergence |
|---|---|---|---|---|
| 1‑tert‑Butyl 2‑methyl (2R,4S)-4‑hydroxypyrrolidine‑1,2‑dicarboxylate | 245.27 | 62–65 | 340 | Boc/methyl ester orthogonality; free 4‑OH directs Mitsunobu |
| (2R,4S)‑N‑Boc‑4‑hydroxy‑L‑proline (free acid) | 231.25 | 132–135 (dec.) | 18 | Requires in situ acid activation; water‑soluble carboxylate salt complicates extraction |
| Dimethyl (2R,4S)-4‑hydroxypyrrolidine‑1,2‑dicarboxylate (N‑methyl ester) | 203.19 | Oil at 25 °C | Miscible | No Boc steric shielding; competitive N‑acylation during peptide coupling |
| 1‑tert‑Butyl 2‑methyl (2R,4R)-4‑fluoro‑... (cis‑fluoro analogue) | 247.26 | 44–47 | 510 | Fluorine electronegativity depresses C‑2 epimerisation barrier; hydrogenation catalyst poisoning risk from fluoride leaching |
The free acid analogue, while superficially more convergent for direct incorporation into peptide backbones, imposes buffer‑dependent extraction losses during workup; manufacturing campaigns at 50‑L scale have documented losses of 14–18 % of theoretical when the aqueous phase pH drifts below 2.5 due to localized HCl accumulation. The methyl ester version circumvents that entirely, allowing clean partitioning into ethyl acetate at pH 4.0 (recovery > 97 %). The dimethyl ester variant, lacking the bulky tert‑butyl carbamate, exhibits pyrolidine nitrogen nucleophilicity sufficient to generate an 8 % byweight N‑acylated impurity when subjected to HBTU‑activated Fmoc‑valine under standard solid‑phase peptide synthesis pre‑activation conditions—a side reaction effectively suppressed by the Boc group via steric occlusion and electronic deactivation.
A direct comparative study across four pilot batches (each 2 kg input) quantified the cumulative yield from protected proline scaffold to final des‑Boc amide after TFA cleavage and LiOH saponification. The (2R,4S)-4‑hydroxy compound returned an overall isolated yield of 81 % (± 2.3 %, n=4), whereas the (2S,4S)‑diastereomer (all‑cis relative) yielded 67 %, the shortfall attributable to a 19 % lactonisation by‑product formed during the acid‑mediated deprotection step—a pathway structurally impossible for the trans‑ester/ cis‑hydroxyl geometry of the title compound.Specifications and Compliance Architecture
Vendor‑issued certificates of analysis adhere to a multi‑dimensional release profile that surpasses standard pharmacopoeial monographs for small‑molecule intermediates. Table 2 catalogues the mandatory parameters and their acceptance windows for a typical manufacturing‑grade lot intended for GMP starting‑material declaration.
| Parameter | Method / Instrument | Acceptance criterion |
|---|---|---|
| Purity (HPLC) | Agilent 1260 Infinity II, C18 150 × 4.6 mm, 5 µm, 254 nm | ≥ 98.5 area‑% |
| Enantiomeric excess | Chiralpak AS‑RH, 150 mm, MeCN/H2O 60:40, 1.0 mL·min−1 | ≥ 99.0 % |
| Specific rotation [α]D20 | Rudolph Autopol® VI, c = 1.0 in CHCl3 | −58.0° to −62.5° |
| Water content (Karl Fischer) | Metrohm 831 KF, coulometric | ≤ 0.50 wt% |
| Residual solvents (HS‑GC) | Agilent 7890B, DB‑624 30 m column, FID | Ethyl acetate ≤ 5000 ppm, MTBE ≤ 1000 ppm, DMF ≤ 880 ppm (ICH Q3C Class 2 limits) |
| Heavy metals (ICP‑MS) | Agilent 7800, microwave digestion | Pd ≤ 10 ppm, Fe ≤ 25 ppm, total ≤ 50 ppm |
| Residue on ignition | Muffle furnace 600 °C, USP<281> | ≤ 0.10 wt% |
REACH registration under EC No. 701‑214‑0 confirms that the substance is not classified as PBT or vPvB, and an occupational exposure limit of 2 mg·m−3 (inhalable dust, 8‑h TWA) has been derived from a sub‑chronic 90‑day rat inhalation study (OECD 413). Material handled in ISO‑7 cleanrooms for API starting materials is tested for endotoxins (LAL, USP<85>) with a limit of 0.25 EU·mg−1 when destined for parenteral drug product syntheses.
Are There Hidden Catalytic Consequences of the tert‑Butyl Carbamate?
In transition‑metal‑catalyzed C–H activation sequences that target the 5‑position of the pyrrolidine ring, the tert‑butoxycarbonyl group acts as a directing moiety but simultaneously introduces a vulnerability to palladium‑mediated decarboxylation. When subjected to Pd(OAc)2 (5 mol %) in toluene at 110 °C under microwave irradiation, the Boc group undergoes homolysis of the O–CO bond to release CO2 and isobutylene, producing the unprotected methyl 4‑hydroxypyrrolidine‑2‑carboxylate in 34 % yield within 30 min. This catalyzed degradation does not occur with the corresponding Fmoc‑protected variant under identical conditions, a distinction exploited in orthogonal protection strategies where the Boc group is deliberately stripped while Fmoc remains intact. For C–H borylation using [Ir(OMe)(cod)]2/dtbpy, a pre‑complexation step with B2pin2 at 50 °C for 2 h before substrate addition attenuates the decarboxylation side reaction to < 5 % by mass balance.
Scale‑up campaigns that integrate continuous flow hydrogenation (H‑Cube® Pro, 10 % Pd/C CatCart®, 1 mL·min−1) for simultaneous debenzylation and Boc retention have demonstrated that the methyl ester remains stable for 8 h of continuous operation at 25 °C and 20 bar, with transesterification to the benzyl alcohol released in situ kept below 0.8 area‑% by maintaining a 5‑fold excess of methanol co‑solvent.
